Allspring Global Investments
REGN icon

Allspring Global Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

Allspring Global Investments’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.5M Buy
69,700
+17,203
+33% +$11.7M 0.07% 338
2026
Q1 		$40.8M Buy
52,497
+14,938
+40% +$11.4M 0.07% 331
2025
Q4 		$29.2M Buy
37,559
+10,759
+40% +$7.31M 0.05% 438
2025
Q3 		$16.1M Sell
26,800
-6,253
-19% -$3.54M 0.03% 585
2025
Q2 		$17.7M Sell
33,053
-6,577
-17% -$3.67M 0.03% 548
2025
Q1 		$24.5M Sell
39,630
-3,844
-9% -$2.64M 0.04% 469
2024
Q4 		$31.1M Sell
43,474
-13,647
-24% -$11.5M 0.05% 421
2024
Q3 		$60M Buy
57,121
+158
+0.3% +$176K 0.09% 264
2024
Q2 		$59.9M Sell
56,963
-1,254
-2% -$1.22M 0.1% 259
2024
Q1 		$56M Buy
58,217
+5,918
+11% +$5.63M 0.09% 287
2023
Q4 		$45.9M Buy
52,299
+18,361
+54% +$15.1M 0.08% 343
2023
Q3 		$27.9M Sell
33,938
-16,700
-33% -$13.1M 0.05% 462
2023
Q2 		$36.4M Buy
50,638
+14,215
+39% +$11M 0.06% 424
2023
Q1 		$29.9M Sell
36,423
-3,243
-8% -$2.45M 0.05% 469
2022
Q4 		$28.6M Sell
39,666
-1,269
-3% -$936K 0.05% 475
2022
Q3 		$28.2M Sell
40,935
-35,007
-46% -$22M 0.05% 470
2022
Q2 		$44.9M Sell
75,942
-5,355
-7% -$3.48M 0.08% 338
2022
Q1 		$56.8M Sell
81,297
-16,496
-17% -$10.4M 0.07% 341
2021
Q4 		$61.8M Buy
+97,793
New +$60.1M 0.07% 366

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Allspring Global Investments's REGN Position: Q2 2026 in Review

Allspring Global Investments increased its Regeneron Pharmaceuticals (REGN) stake by 33% in Q2 2026, buying an estimated $11.7M and bringing the position to 69,700 shares worth $43.5M. The position accounts for 0.07% of the portfolio, ranked #338.

Allspring Global Investments first reported a position in REGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $61.8M in Q4 2021. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Allspring Global Investments held 69,700 shares of Regeneron Pharmaceuticals worth $43.5M as of Q2 2026.
  • Allspring Global Investments bought 17,203 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $11.7M.
  • Regeneron Pharmaceuticals made up 0.07% of Allspring Global Investments's portfolio in Q2 2026, its #338 holding.
  • Allspring Global Investments first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • Allspring Global Investments's Regeneron Pharmaceuticals position peaked at $61.8M in Q4 2021.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.